AN EVALUATION ON PHARMACOECONOMIC ASSESSMENTS AND ETHICAL PERSPECTIVE OF THE TURKISH PHARMACEUTICAL INDUSTRY TO RELATED ISSUE

Oral M1, Ozcelikay G2 OBJECTIVES: Pharmacoeconomics is a scientific discipline handling the comparison of medicines utilized for prevention, diagnosis, and treatment of diseases under the scopes of efficiency and economy. Extrapolation of the results reached according to the pharmacoeconomic analysis methods may be required to make comments. Pharmacoeconomic modeling methods have been developed according to this need. Ethics refers to the moral judgments of a person about true and wrong. The scopes of this study are to determine the usage rates of pharmacoeconomic evaluation methods by the Turkish Pharmaceutical Industry (TPI) and to explore ethical perspective of the TPI while using pharmacoeconomic methods. METHODS: In this study, the questionnaries were held regarding the pharmacoeconomics and ethics to the TPI. According to the findings obtained from questionnaires, usage rates of pharmacoeconomic analysis and modelling methods in TPI are discussed by considering the ethical perspective. RESULTS: It is determined that pharmacoeconomic evaluations are not performed at high rate in the TPI and pharmacoeconomic analysis methods are used higher than the modeling methods, the most used pharmacoeconomic analysis method is the cost effectiveness analysis and the most used modeling method is the decision analysis in the TPI and there is a lack of information on pharmacoeconomic modeling methods in TPI and these methods are mostly not used. CONCLUSIONS: The TPI needs training in pharmacoeconomics and ethical issues and does not attach high importance to the ethical principle of beneficence which is one of the basic ethical principles within the scope of pharmacoeconomic evaluations.